Immune-mediated tumor regression induced by CpG-containing oligodeoxynucleotides

Clinical Cancer Research

Volumn 9, Issue 7, 2003, Pages 2693-2700

  Baines, Jonathan ^b   Celis, Esteban ^a,b  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OLIGODEOXYNUCLEOTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER MODEL; CANCER REGRESSION; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CPG ISLAND; FEMALE; IMMUNE SYSTEM; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL TIME; T LYMPHOCYTE; TUMOR CELL; TUMOR VOLUME; UTERINE CERVIX CARCINOMA; VACCINATION;

ANIMALS; CARCINOMA; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CPG ISLANDS; DISEASE MODELS, ANIMAL; DNA METHYLATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OLIGONUCLEOTIDES; TIME FACTORS; TRANSFECTION; UTERINE CERVICAL NEOPLASMS;

EID: 0037479773     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Parkin, D. M. Epidemiology of cancer: global patterns and trends. Toxicol. Lett., 102-103: 227-234, 1998.
2. zur Hausen, H. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer, 2: 342-350, 2002.
3. von Knebel Doeberitz, M., Rittmuller, C., zur Hausen, H., and Durst, M. Inhibition of tumorigenicity of cervical cancer cells in nude mice by HPV E6-E7 anti-sense RNA. Int. J. Cancer, 51: 831-834, 1992.
4. Da Silva, D. M., Eiben, G. L., Fausch, S. C., Wakabayashi, M. T., Rudolf, M. P., Velders, M. P., and Kast, W. M. Cervical cancer vaccines: emerging concepts and developments. J. Cell Physiol., 186: 169-182, 2001.
5. Ressing, M. E., van Driel, W. J., Brandt, R. M., Kenter, G. G., de Jong, J. H., Bauknecht, T., Fleuren, G. J., Hoogerhout, P., Offringa, R., Sette, A., Celis, E., Grey, H., Trimbos, B. J., Kast, W. M., and Melief, C. J. Detection of T helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma. J. Immunother., 23: 255-266, 2000.
6. Steller, M. A., Gurski, K. J., Murakami, M., Daniel, R. W., Shah, K. V., Celis, E., Sette, A., Trimble, E. L., Park, R. C., and Marincola, F. M. Cell-mediated immunological responses in cervical and vaginal cancer patients immunized with a lipidated epitope of human papillomavirus type 16 E7. Clin. Cancer Res., 4: 2103-2109, 1998.
7. Bubenik, J. Animal models for development of therapeutic HPV16 vaccines. Int. J. Oncol., 20: 207-212, 2002.
8. Feltkamp, M. C., Smits, H. L., Vierboom, M. P., Minnaar, R. P., de, J. B. M., Drijfhout, J. W., ter Schegget, J., Melief, C. J., and Kast, W. M. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur. J. Immunol., 23: 2242-2249, 1993.
9. Mayordomo, J. I., Zorina, T., Storkus, W. J., Celluzzi, C., Falo, L., Kast, W. M., Ildstad, S. T., DeLeo, A. B., and Lotze, M. T. Bone marrow-derived dendritic cells pulsed with tumor peptides elicit protective and therapeutic anti-tumor immunity. Nat. Med., 1: 1297-1303, 1995.
10. Buteau, C., Markovic, S. N., and Celis, E. Challenges in the development of effective peptide vaccines for cancer. Mayo Clin. Proc., 77: 339-349, 2002.
11. Krieg, A. M. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol., 20: 709-760, 2002.
12. Wagner, H. Interactions between bacterial CpG-DNA and TLR9 bridge innate and adaptive immunity. Curr. Opin. Microbiol., 5: 62-69, 2002.
13. Davila, E., and Celis, E. Repeated administration of cytosine-phosphorothiolated guanine-containing oligonucleotides together with peptide/protein immunization results in enhanced CTL responses with anti-tumor activity. J. Immunol., 165: 539-547, 2000.
14. Ballas, Z. K., Krieg, A. M., Warren, T., Rasmussen, W., Davis, H. L., Waldschmidt, M., and Weiner, G. J. Divergent therapeutic and immunologic effects of oligodeoxynucleotides with distinct CpG motifs. J. Immunol., 167: 4878-4886, 2001.
15. Velders, M. P., McElhiney, S., Cassetti, M. C., Eiben, G. L., Higgins, T., Kovacs, G. R., Elmishad, A. G., Kast, W. M., and Smith, L. R. Eradication of established tumors by vaccination with Venezuelan equine encephalitis virus replicon particles delivering human papillomavirus 16 E7 RNA. Cancer Res., 61: 7861-7867, 2001.
16. Hung, K., Hayashi, R., Lafond-Walker, A., Lowenstein, C., Pardoll, D., and Levitsky, H. The central role of CD4(+) T cells in the antitumor immune response. J. Exp. Med., 188: 2357-2368, 1998.
17. Giuntoli, R. L., II, Lu, J., Kobayashi, H., Kennedy, R., and Celis, E. Direct costimulation of tumor-reactive CTL by helper T cells potentiate their proliferation, survival, and effector function. Clin. Cancer Res., 8: 922-931, 2002.
18. Medzhitov, R. Toll-like receptors and innate immunity. Nat. Rev. Immunol., 1: 135-145, 2001.
19. Janeway, C. A., Jr., and Medzhitov, R. Innate immune recognition. Annu. Rev. Immunol., 20: 197-216, 2002.
20. Lanuti, M., Rudginsky, S., Force, S. D., Lambright, E. S., Siders, W. M., Chang, M. Y., Amin, K. M., Kaiser, L. R., Scheule, R. K., and Albelda, S. M. Cationic lipid:bacterial DNA complexes elicit adaptive cellular immunity in murine intraperitoneal tumor models. Cancer Res., 60: 2955-2963, 2000.
21. Carpentier, A. F., Xie, J., Mokhtari, K., and Delattre, J. Y. Successful treatment of intracranial gliomas in rat by oligodeoxynucleotides containing CpG motifs. Clin. Cancer Res., 6: 2469-2473, 2000.
22. Kawarada, Y., Ganss, R., Garbi, N., Sacher, T., Arnold, B., and Hammerling, G. J. NK- and CD8(+) T cell-mediated eradication of established tumors by peritumoral injection of CpG-containing oligodeoxynucleotides. J. Immunol., 167: 5247-5253, 2001.
23. Maurer, T., Heit, A., Hochrein, H., Ampenberger, F., O'Keeffe, M., Bauer, S., Lipford, G. B., Vabulas, R. M., and Wagner, H. CpG-DNA aided cross-presentation of soluble antigens by dendritic cells. Eur. J. Immunol., 32: 2356-2364, 2002.
24. den Haan, J. M., Lehar, S. M., and Bevan, M. J. CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med., 192: 1685-1696, 2000.
25. Pooley, J. L., Heath, W. R., and Shortman, K. Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8- dendritic cells, but cross-presented to CD8 T cells by CD8+ dendfitic cells. J. Immunol., 166: 5327-5330, 2001.
26. Davila, E., Velez, M. G., Heppelmann, C. J., and Celis, E. Creating space: an antigen-independent, CpG-induced peripheral expansion of naive and memory T lymphocytes in a full T-cell compartment. Blood, 100: 2537-2545, 2002.
27. Bennett, S. R., Carbone, F. R., Karamalis, F., Miller, J. F., and Heath, W. R. Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help. J. Exp. Med., 186: 65-70, 1997.
28. Sakaguchi, S., Sakaguchi, N., Shimizu, J., Yamazaki, S., Sakihama, T., Itoh, M., Kuniyasu, Y., Nomura, T., Toda, M., and Takahashi, T. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev., 182: 18-32, 2001.
29. Shevach, E. M. CD4+ CD25+ suppressor T cells: more questions than answers. Nat. Rev. Immunol., 2: 389-400, 2002.
30. Wilcox, R. A., Flies, D. B., Zhu, G., Johnson, A. J., Tamada, K., Chapoval, A. I., Strome, S. E., Pease, L. R., and Chen, L. Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors. J. Clin. Investig., 109: 651-659, 2002.
31. Kim, T. Y., Myoung, H. J., Kim, J. H., Moon, I. S., Kim, T. G., Ahn, W. S., and Sin, J. I. Both E7 and CpG-oligodeoxynucleotide are required for protective immunity against challenge with human papillomavirus 16 (E6/E7) immortalized tumor cells: involvement of CD4+ and CD8+ T cells in protection. Cancer Res., 62: 7234-7240, 2002.